An Air India pilot tested positive for drugs following a turbulence incident on flight AI2379 that injured 17 passengers [1].
The incident raises serious questions about cockpit safety and pilot impairment. If the pilot was incapacitated or impaired during a critical flight event, it could indicate a systemic failure in airline screening and safety protocols.
The flight was traveling from Phuket, Thailand, to Delhi, India [1]. During the journey, the aircraft experienced a sudden loss of altitude of 300 feet [1]. This drop was attributed to turbulence, which resulted in injuries to 17 passengers [1].
Investigators are now probing the circumstances surrounding the flight. Reports indicate that the pilot underwent drug testing as part of the probe into the altitude loss. A second drug test reportedly returned a positive result [1].
Air India and aviation authorities are examining whether the pilot's condition contributed to the handling of the turbulence or if the altitude loss was an unavoidable atmospheric event. The investigation aims to determine the timeline of the pilot's impairment relative to the flight's operation [2].
The aircraft's flight path and cockpit voice recordings are typically reviewed in such cases to assess pilot response times and decision-making during the drop. Officials are working to confirm the specific substances found in the second test [2].
“An Air India pilot tested positive for drugs following a turbulence incident.”
This incident highlights the critical intersection of crew health and aviation safety. While turbulence is a common meteorological occurrence, the discovery of a positive drug test transforms a routine safety event into a potential criminal or regulatory violation. The outcome of this probe may lead to stricter pre-flight screening requirements for Air India and could prompt a wider audit of pilot wellness and substance abuse monitoring across the carrier's fleet.
